Gene Therapy Bioprocessing Solutions

On this page:

Powering results across gene therapy workflows

Gene therapy manufacturing requires precision across every stage, as even small variations can affect vector yield, purity, and consistency. Thermo Fisher Scientific connects upstream and downstream operations through integrated bioprocessing solutions that unite cell culture, transfection, purification, and analytical tools. This integration helps teams reduce variability, improve reproducibility, and maintain quality from early development through commercial manufacturing.

Overcome complexity in gene therapy production

Gene therapy manufacturing presents distinct challenges, from low viral vector yields to complex multistep processes and evolving regulatory expectations. These factors can slow progress and increase production risk. Simplify complexity in adeno-associated virus (AAV) and lentivirus (LV) manufacturing with connected, scalable production platforms that reduce variability and advance clinical readiness.
 

Improve performance with connected gene therapy processes

Optimizing gene therapy depends on how each step connects. Thermo Fisher Scientific integrates media, transfection, purification, and analytical solutions to help improve productivity and reproducibility across workflows. Aligning upstream and downstream operations helps reduce variability, improve reproducibility, and accelerate the path from development to manufacturing.

Optimize upstream processing


Efficient gene therapy upstream bioprocessing lays the foundation for scalable gene therapy production. Thermo Fisher Scientific supports vector generation from cell line selection and expansion to transfection and harvest with optimized Gibco media, feeds, single-use systems, and advanced bioreactor technologies. Scale high-density cell culture efficiently with the Thermo Scientific DynaDrive Single-Use Bioreactor designed to achieve consistent yields and smooth transitions to manufacturing.

Enhance downstream processing


After vector harvest, downstream operations focus on purification, concentration, and final formulation to achieve consistent product quality. Affinity chromatography resins allow selective vector recovery, while 96-well screening plates simplify resin selection and process optimization. Maintain purity and throughput to final formulation with purification tools, filtration technologies, and fill-finish solutions that reduce manual handling.
 

Solutions designed for AAV and LV production

Gene therapy programs often rely on different viral vector systems, each with specific process needs. Standardize AAV and LV manufacturing using scalable, compatible technologies that reduce process variation and support consistent quality.

Simplify AAV production


Accelerate AAV scale-up with the Gibco AAV-MAX Helper-Free AAV Production System that combines media, reagents, and protocols to support reproducible AAV vector generation in suspension culture. When paired with the DynaDrive Single-Use Bioreactor, Thermo Scientific POROS CaptureSelect AAVX Affinity Resin and membranes, this solution supports consistent yield and recovery across scales. These components form an AAV production platform that maintains performance from early development through commercial manufacturing.

Streamline LV production


Simplify scale-up and reduce variability with the Gibco LV-MAX Lentiviral Production Systemdesigned to support high-titer vector production across development and manufacturing stages. With fewer manual steps, developers can enhance productivity from batch to batch.
 

Optimize gene therapy manufacturing


Scaling gene therapy from development to commercial production requires materials that perform consistently under regulated conditions. Thermo Fisher Scientific supplies cGMP-manufactured reagents, single-use consumables, and automation tools that maintain process stability as production volumes grow. Our global manufacturing and supply network supports continuity and offers the documentation needed for regulatory review.

Collaboration that accelerates innovation

Refining gene therapy processes often depends on shared experiences. Thermo Fisher Scientific connects developers with technical scientists who specialize in upstream, downstream, and analytical methods. Work conducted in shared innovation centers enables direct collaboration, process evaluation, and knowledge transfer, shortening development cycles and strengthening manufacturing readiness.
 

Frequently asked questions

Gene therapy bioprocessing solutions are the integrated tools and systems used to produce viral vectors safely and efficiently for clinical use. They combine specialized media, single-use technologies, transfection systems, and purification resins designed for AAV and LV production. Unlike traditional biologics manufacturing, these solutions focus on generating and maintaining functional viral particles that facilitate therapeutic genes to target cells.

Thermo Fisher Scientific supports both AAV and LV manufacturing through connected upstream and downstream workflows. For AAV production, the Gibco AAV-MAX Helper-Free AAV Production System, DynaDrive Single-Use Bioreactor, and POROS CaptureSelect AAVX Affinity Resin are used to produce and purify viral vectors. For LV, the Gibco LV-MAX Lentiviral Production System supports scalable vector generation from research through manufacturing. These solutions work together to maintain yield, purity, and reproducibility from development through manufacturing.

Upstream processing involves cell growth and vector production steps such as transfection and harvest, while downstream processing focuses on purification, concentration, and formulation of viral vectors. Upstream and downstream processing are important to achieve consistent vector quality and potency in gene therapy manufacturing.

Thermo Fisher Scientific’s gene therapy solutions are distinguished by global scale, supply chain reliability, and comprehensive platform depth from plasmid DNA production through fill and finish. Materials are manufactured under cGMP conditions and supported by detailed regulatory documentation. This combination of reach, consistency, and compliance helps developers maintain reliable supply and quality across every stage of gene therapy manufacturing.

Discover gene therapy resources

Access technical guidance and reference materials that support every stage of gene therapy development and manufacturing. Explore webinars, application notes, and workflow guidance designed to help improve yield, manage complexity, and meet regulatory expectations.

Explore other bioprocessing applications

Thermo Fisher Scientific supports a broad range of bioprocessing applications, including monoclonal antibodies (mAbs), cell therapy, gene therapy, and vaccine production. Our solutions are designed to maintain consistency and scalability across diverse therapeutic modalities.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.